Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
New Study Shows Smoking Tobacco Doubles Risk of Recurrent Tuberculosis

The study is the most robust ever conducted into how smoking tobacco increases the risk of recurrent TB. It appears in the April issue of the International Journal of Tuberculosis and Lung Disease.Regular tobacco smokers were defined as individuals who smoked 10 or more cigarettes—equivalent to half a pack—per day.

Published
24 March 2014
From
International Union Against Tuberculosis and Lung Disease
Poor Diagnosis Driving Global Multidrug-Resistant TB, WHO Warns

In 2012, fewer than 25 percent of the 500,000 people with multidrug-resistant TB (MDR TB) infections received a diagnosis, according to the World Health Organization (WHO). As a result, many MDR TB-infected individuals received the wrong treatment or no treatment at all.

Published
24 March 2014
From
Reuters
Tuberculosis cases down by 6% but only 1 in 3 MDR TB patients finishes treatment successfully

In 2012, 68 423 cases of tuberculosis (TB) were reported in 29 EU/EEA countries according to new data published by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe ahead of World Tuberculosis Day.

Published
19 March 2014
From
ECDC
China 'has halved its TB problem'

China has more than halved its tuberculosis (TB) prevalence, with rates falling from 170 to 59 per 100,000 of population, figures suggest.

Published
18 March 2014
From
BBC Health
Public Health England Study Examines Spread of MDR-TB

Vaccine News Daily reported on a Public Health England (PHE) study of multidrug-resistant TB (MDR TB) in the United Kingdom. According to PHE, MDR TB cases increased from 28 cases per year to 81 in the past 12 years for a total of approximately 681 confirmed cases between 2000 and 2012.

Published
17 March 2014
From
CDC National Prevention Information Network
South Africa Battles Drug-Resistant TB

Despite an increase in diagnosis times, South Africa is facing a growing drug-resistant tuberculosis (TB) burden as nationally there remains a large gap between the number of patients diagnosed with multidrug-resistant TB (MDR-TB) and those who start treatment.

Published
12 March 2014
From
Inter Press Service
Xpert TB test doesn’t reduce morbidity but it does have important advantages

While it is disappointing that the Xpert did not confer a morbidity or mortality benefit, its advantages include quicker and easier diagnosis with less work for health workers.

Published
10 March 2014
From
HIV i-Base
Despite progress, tuberculosis persists in West European cities

Tuberculosis is becoming concentrated among immigrants, drug addicts, and the poor and homeless in Western Europe's big cities despite progress in reducing national rates of the disease, experts said on Friday.

Published
10 March 2014
From
Reuters
Rifapentine, moxifloxacin active as part of shorter TB regimen

A shorter treatment regimen consisting of rifapentine, moxifloxacin, isoniazid and pyrazinamide was more active than a control regimen against drug-susceptible pulmonary tuberculosis, researchers reported at the 2014 Conference on Retroviruses and Opportunistic Infections.

Published
10 March 2014
From
Healio
SIRTURO® (bedaquiline) Receives Conditional Approval in the European Union for the Treatment of Multi-Drug Resistant Tuberculosis

Janssen-Cilag International NV (Janssen) announced today that the European Commission (EC) has granted conditional approval to SIRTURO® (bedaquiline) in the European Union, for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (MDR-TB) in adult patients, when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

Published
07 March 2014
From
Janssen press release

Filter by country